Market positioning Target preclinical R&D buyers in pharma, biotech, and medical device sectors who require safety, toxicology, and efficacy studies with strong regulatory and quality compliance heritage.

Clinical value focus Highlight Synchrony Labs’ four decades of experience and its origin at Duke Medical Center to position as a trusted partner that accelerates transition from concept to clinical study while mitigating testing and regulatory risks.

Expansion signals Recent structural heart center launch and ongoing growth imply opportunities with cardiovascular devices and related therapies; tailor outreach to firms seeking preclinical support for niche device indications.

Compliance credibility Emphasize a stellar compliance record and end-to-end CRO services to address buyer pain points around audit readiness, quality standards, and streamlined study execution.

Growth readiness With mid-market revenue and a lean team, position Synchrony Labs as a cost-efficient partner capable of scaling preclinical programs for mid-sized pharma/biotech firms seeking faster time-to-study and predictable budgeting.